Agra Ventures Announces Details of Share Consolidation

The Company’s Common Shares Are Expected to Begin Trading With New CUSIP and ISIN Numbers on or about August 27, 2021

VANCOUVER, British Columbia, Aug. 25, 2021 (GLOBE NEWSWIRE) —

Agra Ventures Ltd.


(“AGRA”


or


the


“Company”)


(CSE: AGRA)


(Frankfurt:


PU31)


(OTCPK:


AGFAF),

a growth-oriented and diversified company focused on the international cannabis industry, announces that pursuant to a director’s resolution AGRA will be consolidating all of its issued and outstanding share capital on the basis of one (1) post‐consolidation share for each one hundred and fifty (150) pre‐consolidation common shares of the Company (the “

Consolidation

”). No fractional shares will be issued by AGRA under the Consolidation and any fraction will be rounded to the nearest whole number.

As a result, the outstanding common shares of the Company will be reduced to approximately 12,986,374. The exercise or conversion price and the number of common shares issuable under any of AGRA’s outstanding convertible securities will be proportionately adjusted upon consolidation. In connection with the Consolidation, the name of the Company will not change and its trading symbol will remain as “AGRA”. The Company’s common shares are expected to begin trading on a consolidated basis and with a new CUSIP number of 008505208 and a new ISIN number of CA0085052086 on or about August 27, 2021.


About


Agra Ventures Ltd.

Agra Ventures is a growth-oriented and diversified company focused on the international cannabis industry. The company is dedicated to the cultivation, distribution and marketing of high-quality cannabis and cannabis-infused products worldwide. Agra Ventures’ primary asset in Canada is Boundary Bay Cannabis located in Delta, BC, which is one of the largest cannabis greenhouse facilities focused on the cost-optimized cultivation of high-potency cannabis. Abroad, the company’s wholly-owned subsidiary, Farmako GmbH, is focused on becoming Europe’s leading distributor of medical cannabis. Farmako currently has active product distribution operations in Germany and expects to commence active operations in the United Kingdom in 2021.

For more information about Agra Ventures, please visit

agraventures.com

and its profile page on SEDAR at


www.sedar.com

.



ON




BEHALF




OF




THE




BOARD




OF




DIRECTORS



Nick Kuzyk, Investor Relations E:

[email protected]


T: (800) 783-6056


For


French


inquiries:


Maricom Inc. Remy Scalabrini E:


[email protected]



T: (888) 585-MARI


The


CSE


and


Information


Service


Provider


have


not


reviewed


and


does


not


accept


responsibility


for


the


accuracy


or


adequacy


of


this


release.



Forward-looking




Information




Cautionary




Statement




Except


for


statements


of


historic


fact


this


news


release


contains


certain


“forward-looking


information” within the meaning of applicable securities law. Forward-looking information is


frequently


characterized


by


words


such


as


“plan”


“expect”


“project”


“intend”


“believe”


“anticipate” “estimate” and other similar words or statements that certain events or conditions


“may” or “will” occur. Forward-looking statements are based on the opinions and estimates at


the date the statements are made and are subject to a variety of risks and uncertainties and other


factors that could cause actual events or results to differ materially from those anticipated in the


forward-looking statements including but not limited to delays or uncertainties with regulatory


approvals


including


that


of


the


CSE.


There


are


uncertainties


inherent


in


forward-looking


information including factors beyond the Company’s control. There are no assurances that the


business


plans


for


Agra Ventures described


in


this


news


release


will


come


into


effect


on


the terms or time frame described herein. The Company undertakes no obligation to update


forward-looking information if circumstances or management’s estimates or opinions should


change except as required by law. The reader is cautioned not to place undue reliance on


forward-looking statements. Additional information identifying risks and uncertainties that could


affect financial results is contained in the Company’s filings with Canadian securities regulators


which


are


available


at



www.sedar.com.



Primary Logo